Latest News

Kyowa Kirin and MEI Pharma Announce First Patient Dosed in Japanese Pivotal Phase 2 Study of Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma
MEI Pharma Appoints Brian T. Powl As Senior Vice President, Marketing
MEI Pharma Reports Fiscal Year 2020 Results and Operational Highlights
MEI Pharma to Present at Upcoming Investor Conferences in September